Operating Lease, Right-of-Use Asset of Stoke Therapeutics, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Stoke Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Stoke Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,708,000, a 25% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Stoke Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,708,000 -$1,220,000 -25% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $3,218,000 -$2,281,000 -41% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $3,831,000 -$2,229,000 -37% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $4,345,000 -$2,266,000 -34% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $4,928,000 +$1,844,000 +60% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $5,499,000 +$1,853,000 +51% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $6,060,000 +$1,858,000 +44% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $6,611,000 +$1,858,000 +39% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $3,084,000 -$2,211,000 -42% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $3,646,000 -$2,185,000 -37% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $4,202,000 -$361,000 -7.9% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $4,753,000 -$186,000 -3.8% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 $5,295,000 -$31,000 -0.58% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $5,831,000 +$4,573,000 +364% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $4,563,000 +$3,719,000 +441% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $4,939,000 +$3,824,000 +343% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 $5,326,000 +$3,945,000 +286% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $1,258,000 -$384,000 -23% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $844,000 -$1,056,000 -56% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $1,115,000 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $1,381,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $1,642,000 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $1,900,000 31 Mar 2020 10-Q 15 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.